John B. Landis

Insider Reports History

Entity
Individual
Location
1700 Kent Avenue, West Lafayette, IN
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Landis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 21.4K $186K $8.68 Jan 5, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Restricted Stock Units 0 $0 $8.68 Jan 5, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K Jan 3, 2025 Direct

Insider Reports Filed by John B. Landis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EYPT EyePoint Pharmaceuticals, Inc. Jan 3, 2025 3 $0 4 Jan 7, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 3 $0 4 Jan 9, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2023 2 $0 4 Feb 13, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2022 4 $0 4 Feb 11, 2022 Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 22, 2021 2 $0 4 Jun 23, 2021 Director